An excisional biopsy is performed and the diagnosis of superficial spreading melanoma is confirmed. The lesion is 1.1 mm thick. Which of the following is the most appropriate next step in management?
Q2
A 64-year-old woman presents to the surgical oncology clinic as a new patient for evaluation of recently diagnosed breast cancer. She has a medical history of type 2 diabetes mellitus for which she takes metformin. Her surgical history is a total knee arthroplasty 7 years ago. Her family history is insignificant. Physical examination is notable for an irregular nodule near the surface of her right breast. Her primary concern today is which surgical approach will be chosen to remove her breast cancer. Which of the following procedures involves the removal of a portion of a breast?
Q3
A 70-year-old man comes to the physician because of right-sided back pain, red urine, and weight loss for the last 4 months. He has smoked one pack of cigarettes daily for 40 years. A CT scan of the abdomen shows a large right-sided renal mass. Biopsy of the mass shows polygonal clear cells filled with lipids. Which of the following features is necessary to determine the tumor grade in this patient?
Q4
During an evaluation of a new diagnostic imaging modality for detecting salivary gland tumors, 90 patients tested positive out of the 100 patients who tested positive with the gold standard test. A total of 80 individuals tested negative with the new test out of the 100 individuals who tested negative with the gold standard test. What is the positive likelihood ratio for this test?
Q5
A 43-year-old woman presents to your clinic for the evaluation of an abnormal skin lesion on her forearm. The patient is worried because her mother passed away from melanoma. You believe that the lesion warrants biopsy for further evaluation for possible melanoma. Your patient is concerned about her risk for malignant disease. What is the most important prognostic factor of melanoma?
Q6
A 62-year-old woman presents to her primary care physician for a routine physical exam. The patient has no specific complaints but does comment on some mild weight gain. She reports that she recently retired from her job as a math teacher and has taken up hiking. Despite the increase in activity, she believes her pants have become "tighter." She denies headaches, urinary symptoms, or joint pains. She has a history of hypertension, type 2 diabetes, and rheumatoid arthritis. Her medications include aspirin, lisinopril, rovastatin, metformin, and methotrexate. She takes her medications as prescribed and is up to date with her vaccinations. A colonoscopy two years ago and a routine mammography last year were both normal. The patient’s last menstrual period was 10 years ago. The patient has a father who died of colon cancer at 71 years of age and a mother who has breast cancer. Her temperature is 98.7°F (37°C), blood pressure is 132/86 mmHg, pulse is 86/min, respirations are 14/min and oxygen saturation is 98% on room air. Physical exam is notable for a mildly distended abdomen and a firm and non-mobile right adnexal mass. What is the next step in the management of this patient?
Q7
A 28-year-old male presents to his primary care physician with complaints of intermittent abdominal pain and alternating bouts of constipation and diarrhea. His medical chart is not significant for any past medical problems or prior surgeries. He is not prescribed any current medications. Which of the following questions would be the most useful next question in eliciting further history from this patient?
Q8
A 65-year-old man is admitted to the hospital because of a 1-month history of fatigue, intermittent fever, and weakness. Results from a peripheral blood smear taken during his evaluation are indicative of possible acute myeloid leukemia. Bone marrow aspiration and subsequent cytogenetic studies confirm the diagnosis. The physician sets aside an appointed time-slot and arranges a meeting in a quiet office to inform him about the diagnosis and discuss his options. He has been encouraged to bring someone along to the appointment if he wanted. He comes to your office at the appointed time with his daughter. He appears relaxed, with a full range of affect. Which of the following is the most appropriate opening statement in this situation?
Q9
A 47-year-old woman comes to the physician for a mass in her left breast she noticed 2 days ago during breast self-examination. She has hypothyroidism treated with levothyroxine. There is no family history of breast cancer. Examination shows large, moderately ptotic breasts. The mass in her left breast is small (approximately 1 cm x 0.5 cm), firm, mobile, and painless. It is located 4 cm from her nipple-areolar complex at the 7 o'clock position. There are no changes in the skin or nipple, and there is no palpable axillary adenopathy. No masses are palpable in her right breast. A urine pregnancy test is negative. Mammogram showed a soft tissue mass with poorly defined margins. Core needle biopsy confirms a low-grade infiltrating ductal carcinoma. The pathological specimen is positive for estrogen receptors and negative for progesterone and human epidermal growth factor receptor 2 (HER2) receptors. Staging shows no distant metastatic disease. Which of the following is the most appropriate next step in management?
Q10
A 56-year-old woman comes to the physician because she palpated a mass in her right breast during self-examination a week ago. Menarche was at the age of 14, and her last menstrual period was at the age of 51. Vital signs are within normal limits. Examination shows a nontender, firm and hard mass in the upper outer quadrant of the right breast. Mammography shows large, dense breasts, with a 1.7-cm mass in the right upper outer quadrant. The patient undergoes right upper outer quadrant lumpectomy with subsequent sentinel node biopsy, which reveals moderately differentiated invasive ductal carcinoma and micrometastasis to one axillary lymph node. There is no evidence of extranodal metastasis. The tumor tests positive for both estrogen and progesterone receptors and does not show human epidermal growth factor receptor 2 (HER2) over-expression. Flow-cytometry reveals aneuploid tumor cells. Which of the following factors has the greatest effect on this patient's prognosis?
Surgical margins and R0 resection US Medical PG Practice Questions and MCQs
Question 1: An excisional biopsy is performed and the diagnosis of superficial spreading melanoma is confirmed. The lesion is 1.1 mm thick. Which of the following is the most appropriate next step in management?
A. Surgical excision with 0.5-1 cm safety margins only
B. Surgical excision with 1 cm safety margins only
C. Surgical excision with 1-2 cm safety margins only
D. Surgical excision with 0.5-1 cm safety margins and sentinel lymph node study
E. Surgical excision with 1-2 cm safety margins and sentinel lymph node study (Correct Answer)
Explanation: ***Surgical excision with 1-2 cm safety margins and sentinel lymph node study***
- A melanoma with a **Breslow thickness between 1.01 mm and 2.0 mm** (like this 1.1 mm lesion) requires a recommended surgical margin of **1 to 2 cm**.
- For melanomas **≥0.8 mm thickness** (or those with ulceration), a **sentinel lymph node biopsy (SLNB)** is recommended to assess for micrometastasis, as it helps in staging and prognosis.
*Surgical excision with 0.5-1 cm safety margins only*
- A 0.5 cm margin is typically reserved for melanoma *in situ* or extremely thin melanomas (less than or equal to 0.5 mm), and 1 cm for lesions 0.51 to 1.0 mm, which is too narrow for a 1.1 mm lesion.
- This option incorrectly omits the **sentinel lymph node study**, which is indicated for a melanoma of this thickness.
*Surgical excision with 1 cm safety margins only*
- While 1 cm is a common margin for lesions up to 1.0 mm, a 1.1 mm melanoma usually warrants a slightly wider margin, ideally 1-2 cm.
- This option also fails to include the **sentinel lymph node study**, which is crucial for staging melanomas ≥0.8 mm thickness.
*Surgical excision with 0.5-1 cm safety margins and sentinel lymph node study*
- The recommended surgical margin for a 1.1 mm melanoma is at least **1 cm, preferably between 1 and 2 cm**, making a 0.5-1 cm range insufficient.
- Although it correctly includes the sentinel lymph node study, the **surgical margin is inadequate** for the given Breslow thickness.
*Surgical excision with 1-2 cm safety margins only*
- While the **1-2 cm surgical margin** is appropriate for a 1.1 mm melanoma, this option **incorrectly excludes the sentinel lymph node study**.
- The sentinel lymph node biopsy is a critical part of the staging and management plan for melanomas of this thickness to detect potential nodal involvement.
Question 2: A 64-year-old woman presents to the surgical oncology clinic as a new patient for evaluation of recently diagnosed breast cancer. She has a medical history of type 2 diabetes mellitus for which she takes metformin. Her surgical history is a total knee arthroplasty 7 years ago. Her family history is insignificant. Physical examination is notable for an irregular nodule near the surface of her right breast. Her primary concern today is which surgical approach will be chosen to remove her breast cancer. Which of the following procedures involves the removal of a portion of a breast?
A. Arthroplasty
B. Lumpectomy (Correct Answer)
C. Vasectomy
D. Mastectomy
E. Laminectomy
Explanation: ***Lumpectomy***
- A **lumpectomy** is a surgical procedure that removes the **breast cancer tumor** and a small margin of surrounding healthy tissue, preserving most of the breast.
- This procedure is a common treatment for early-stage breast cancer and is often followed by radiation therapy.
*Arthroplasty*
- **Arthroplasty** is a surgical procedure to **repair or replace a joint**, typically due to arthritis or injury.
- The patient's history of a total knee arthroplasty indicates this procedure was performed on her knee, not her breast.
*Vasectomy*
- A **vasectomy** is a surgical procedure for **male sterilization**, involving the cutting and sealing of the vas deferens.
- This procedure is unrelated to breast cancer treatment or breast surgery.
*Mastectomy*
- A **mastectomy** involves the **complete surgical removal of the entire breast**, often including the nipple and areola.
- While it is a breast surgery, it removes the *entire* breast, not just a portion.
*Laminectomy*
- A **laminectomy** is a surgical procedure that removes a portion of the **vertebra (lamina)** to relieve pressure on the spinal cord or nerves.
- This procedure is for spinal conditions and is entirely unrelated to breast cancer surgery.
Question 3: A 70-year-old man comes to the physician because of right-sided back pain, red urine, and weight loss for the last 4 months. He has smoked one pack of cigarettes daily for 40 years. A CT scan of the abdomen shows a large right-sided renal mass. Biopsy of the mass shows polygonal clear cells filled with lipids. Which of the following features is necessary to determine the tumor grade in this patient?
A. Invasion of surrounding structures
B. Response to chemotherapy
C. Nuclear pleomorphism and nucleolar prominence (Correct Answer)
D. Involvement of regional lymph nodes
E. Size of malignant proliferation
Explanation: ***Nuclear pleomorphism and nucleolar prominence***
- The **Fuhrman nuclear grading system** (and newer WHO/ISUP grading system) for renal cell carcinoma is based on **nuclear morphologic features**: nuclear size, nuclear contour irregularity, and most importantly, **nucleolar prominence**.
- **Grade 1**: Small uniform nuclei with inconspicuous nucleoli
- **Grade 2**: Slightly irregular nuclei with small nucleoli visible at 400× magnification
- **Grade 3**: Moderately irregular nuclei with prominent nucleoli visible at 100× magnification
- **Grade 4**: Marked nuclear pleomorphism, multilobated nuclei, and prominent nucleoli
- Higher nuclear grades correlate with more aggressive tumor behavior and worse prognosis.
*Invasion of surrounding structures*
- This feature is crucial for **tumor staging (T stage)**, specifically T3 disease when perinephric fat, renal vein, or IVC is invaded, and T4 when beyond Gerota's fascia.
- **Invasion** determines surgical approach and prognosis related to local spread but does not define histological grade.
*Response to chemotherapy*
- **Response to chemotherapy** is evaluated after treatment and is not a feature used for grading at diagnosis.
- Clear cell RCC is **chemoresistant**; treatment typically involves targeted therapy (VEGF inhibitors, mTOR inhibitors) or immunotherapy, not traditional chemotherapy.
*Involvement of regional lymph nodes*
- **Lymph node involvement** is a component of **tumor staging (N stage)**: N0 (no nodes), N1 (regional nodes positive).
- It indicates metastatic spread and significantly worsens prognosis but does not contribute to **histological grade**, which assesses cellular differentiation.
*Size of malignant proliferation*
- **Tumor size** is the primary criterion for **T staging**: T1a (≤4 cm), T1b (>4-7 cm), T2a (>7-10 cm), T2b (>10 cm), all confined to kidney.
- Size is a prognostic factor but does not determine **histological grade**, which is based exclusively on nuclear microscopic features.
Question 4: During an evaluation of a new diagnostic imaging modality for detecting salivary gland tumors, 90 patients tested positive out of the 100 patients who tested positive with the gold standard test. A total of 80 individuals tested negative with the new test out of the 100 individuals who tested negative with the gold standard test. What is the positive likelihood ratio for this test?
A. 80/90
B. 90/100
C. 90/20 (Correct Answer)
D. 90/110
E. 10/80
Explanation: ***90/20***
- The **positive likelihood ratio (LR+)** is calculated as **sensitivity / (1 - specificity)**. To calculate this, we first need to determine the values for true positives (TP), false positives (FP), true negatives (TN), and false negatives (FN).
- Given that 90 out of 100 actual positive patients tested positive, **TP = 90** and **FN = 100 - 90 = 10**. Also, 80 out of 100 actual negative patients tested negative, so **TN = 80** and **FP = 100 - 80 = 20**.
- **Sensitivity** is the true positive rate (TP / (TP + FN)) = 90 / (90 + 10) = 90 / 100.
- **Specificity** is the true negative rate (TN / (TN + FP)) = 80 / (80 + 20) = 80 / 100.
- Therefore, LR+ = (90/100) / (1 - 80/100) = (90/100) / (20/100) = **90/20**.
*80/90*
- This option incorrectly represents the components for the likelihood ratio. It seems to misinterpret the **true negative** count and the **true positive** count.
- It does not follow the formula for LR+ which is **sensitivity / (1 - specificity)**.
*90/100*
- This value represents the **sensitivity** of the test, which is the proportion of true positives among all actual positives.
- It does not incorporate the **false positive rate** (1 - specificity) in the denominator required for the positive likelihood ratio.
*90/110*
- This option incorrectly combines different values, possibly by confusing the denominator for sensitivity or specificity calculations.
- It does not correspond to the formula for the **positive likelihood ratio**.
*10/80*
- This value seems to relate to the inverse of the **false negative rate** (10/100) or misrepresents the relationship between false negatives and true negatives.
- It is not correctly structured to represent the **positive likelihood ratio (LR+)**.
Question 5: A 43-year-old woman presents to your clinic for the evaluation of an abnormal skin lesion on her forearm. The patient is worried because her mother passed away from melanoma. You believe that the lesion warrants biopsy for further evaluation for possible melanoma. Your patient is concerned about her risk for malignant disease. What is the most important prognostic factor of melanoma?
A. Depth of invasion of atypical cells (Correct Answer)
B. S-100 tumor marker present
C. Evolution of lesion over time
D. Age at presentation
E. Level of irregularity of the borders
Explanation: ***Depth of invasion of atypical cells***
- The **Breslow depth**, which measures the vertical thickness of the melanoma from the granular layer of the epidermis to the deepest part of the tumor, is the **single most important prognostic factor** for localized melanoma.
- A greater depth of invasion correlates directly with a higher risk of **metastasis** and a poorer prognosis due to increased likelihood of reaching dermal lymphatics or blood vessels.
*S-100 tumor marker present*
- While **S-100 protein** is a marker expressed in melanoma cells and can be used to detect metastatic disease (e.g., in lymph nodes), its mere presence does not serve as the primary prognostic indicator for the primary lesion itself.
- S-100 reflects the presence of melanoma cells but does not provide information about the **depth or biological aggressiveness** of the initial tumor.
*Evolution of lesion over time*
- The **evolution or change** in a lesion (e.g., in size, shape, color, new symptoms) is a crucial diagnostic criterion for identifying suspicious lesions for biopsy.
- While important for diagnosis, it is not a direct prognostic factor once melanoma is confirmed; the **pathological features** after biopsy, particularly depth, determine prognosis.
*Age at presentation*
- **Age** can influence treatment decisions and overall health status, but it is not the most important independent prognostic factor for melanoma.
- Prognosis is primarily driven by tumor-specific characteristics rather than the patient's age.
*Level of irregularity of the borders*
- **Border irregularity** is one of the ABCDE criteria (Asymmetry, Border irregularity, Color variation, Diameter >6mm, Evolving) used to identify suspicious pigmented lesions.
- It is a diagnostic indicator that warrants further investigation but does not independently determine **prognosis** as definitively as the Breslow depth after biopsy.
Question 6: A 62-year-old woman presents to her primary care physician for a routine physical exam. The patient has no specific complaints but does comment on some mild weight gain. She reports that she recently retired from her job as a math teacher and has taken up hiking. Despite the increase in activity, she believes her pants have become "tighter." She denies headaches, urinary symptoms, or joint pains. She has a history of hypertension, type 2 diabetes, and rheumatoid arthritis. Her medications include aspirin, lisinopril, rovastatin, metformin, and methotrexate. She takes her medications as prescribed and is up to date with her vaccinations. A colonoscopy two years ago and a routine mammography last year were both normal. The patient’s last menstrual period was 10 years ago. The patient has a father who died of colon cancer at 71 years of age and a mother who has breast cancer. Her temperature is 98.7°F (37°C), blood pressure is 132/86 mmHg, pulse is 86/min, respirations are 14/min and oxygen saturation is 98% on room air. Physical exam is notable for a mildly distended abdomen and a firm and non-mobile right adnexal mass. What is the next step in the management of this patient?
A. Pelvic ultrasound (Correct Answer)
B. Abdominal MRI
C. PET-CT
D. Exploratory laparotomy and debulking
E. CA-125 level
Explanation: ***Pelvic ultrasound***
- A **non-mobile right adnexal mass** in a postmenopausal woman, along with vague symptoms like **abdominal distension** and **weight gain**, raises suspicion for **ovarian cancer**.
- A **pelvic ultrasound** is the initial, non-invasive, and cost-effective imaging modality to characterize adnexal masses, assessing size, morphology, and vascularity.
*Abdominal MRI*
- While **MRI** offers excellent soft tissue contrast, it is typically used as a **secondary imaging modality** for further characterization of adnexal masses when ultrasound findings are inconclusive or for surgical planning, not as the initial step.
- Its higher cost and longer scan time make it less suitable for initial screening compared to ultrasound.
*PET-CT*
- **PET-CT** is primarily used for **staging malignancies** and detecting metastatic disease, or in cases of unknown primary, and is not the initial diagnostic test for an adnexal mass.
- It involves radiation exposure and is generally reserved for situations where malignancy is already highly suspected or confirmed.
*Exploratory laparotomy and debulking*
- **Exploratory laparotomy** and **debulking** are surgical procedures performed for the definitive diagnosis, staging, and treatment of ovarian cancer, but only *after* a thorough initial workup has been completed.
- It is an invasive procedure and should not be the first step in the investigation of an adnexal mass.
*CA-125 level*
- Measuring **CA-125** levels is useful as a **tumor marker** in the workup of suspected ovarian cancer, particularly in symptomatic postmenopausal women, and for monitoring treatment response.
- However, it has **low specificity** (can be elevated in benign conditions) and should be ordered in conjunction with imaging, not as the sole initial diagnostic step.
Question 7: A 28-year-old male presents to his primary care physician with complaints of intermittent abdominal pain and alternating bouts of constipation and diarrhea. His medical chart is not significant for any past medical problems or prior surgeries. He is not prescribed any current medications. Which of the following questions would be the most useful next question in eliciting further history from this patient?
A. "Does the diarrhea typically precede the constipation, or vice-versa?"
B. "Is the diarrhea foul-smelling?"
C. "Please rate your abdominal pain on a scale of 1-10, with 10 being the worst pain of your life"
D. "Are the symptoms worse in the morning or at night?"
E. "Can you tell me more about the symptoms you have been experiencing?" (Correct Answer)
Explanation: ***Can you tell me more about the symptoms you have been experiencing?***
- This **open-ended question** encourages the patient to provide a **comprehensive narrative** of their symptoms, including details about onset, frequency, duration, alleviating/aggravating factors, and associated symptoms, which is crucial for diagnosis.
- In a patient presenting with vague, intermittent symptoms like alternating constipation and diarrhea, allowing them to elaborate freely can reveal important clues that might not be captured by more targeted questions.
*Does the diarrhea typically precede the constipation, or vice-versa?*
- While knowing the sequence of symptoms can be helpful in understanding the **pattern of bowel dysfunction**, it is a very specific question that might overlook other important aspects of the patient's experience.
- It prematurely narrows the focus without first obtaining a broad understanding of the patient's overall symptomatic picture.
*Is the diarrhea foul-smelling?*
- Foul-smelling diarrhea can indicate **malabsorption** or **bacterial overgrowth**, which are important to consider in some gastrointestinal conditions.
- However, this is a **specific symptom inquiry** that should follow a more general exploration of the patient's symptoms, as it may not be relevant if other crucial details are missed.
*Please rate your abdominal pain on a scale of 1-10, with 10 being the worst pain of your life*
- Quantifying pain intensity is useful for assessing the **severity of discomfort** and monitoring changes over time.
- However, for a patient with intermittent rather than acute, severe pain, understanding the **character, location, and triggers** of the pain is often more diagnostically valuable than just a numerical rating initially.
*Are the symptoms worse in the morning or at night?*
- Diurnal variation can be relevant in certain conditions, such as inflammatory bowel diseases where nocturnal symptoms might be more concerning, or functional disorders whose symptoms might be stress-related.
- This is another **specific question** that should come after gathering a more complete initial picture of the patient's symptoms to ensure no key information is overlooked.
Question 8: A 65-year-old man is admitted to the hospital because of a 1-month history of fatigue, intermittent fever, and weakness. Results from a peripheral blood smear taken during his evaluation are indicative of possible acute myeloid leukemia. Bone marrow aspiration and subsequent cytogenetic studies confirm the diagnosis. The physician sets aside an appointed time-slot and arranges a meeting in a quiet office to inform him about the diagnosis and discuss his options. He has been encouraged to bring someone along to the appointment if he wanted. He comes to your office at the appointed time with his daughter. He appears relaxed, with a full range of affect. Which of the following is the most appropriate opening statement in this situation?
A. Your lab reports show that you have an acute myeloid leukemia
B. What is your understanding of the reasons we did bone marrow aspiration and cytogenetic studies? (Correct Answer)
C. You must be curious and maybe even anxious about the results of your tests.
D. I may need to refer you to a blood cancer specialist because of your diagnosis. You may need chemotherapy or radiotherapy, which we are not equipped for.
E. Would you like to know all the details of your diagnosis, or would you prefer I just explain to you what our options are?
Explanation: ***"What is your understanding of the reasons we did bone marrow aspiration and cytogenetic studies?"***
- This **open-ended question** allows the patient to express their current knowledge and perceptions, which helps the physician tailor the discussion.
- It establishes a **patient-centered approach**, respecting the patient's existing understanding and preparing them for further information.
*"You must be curious and maybe even anxious about the results of your tests."*
- While empathic, this statement makes an **assumption about the patient's feelings** rather than inviting them to share their own.
- It is often better to ask directly or use more open-ended questions that allow the patient to express their true emotions, especially given their **relaxed demeanor**.
*"I may need to refer you to a blood cancer specialist because of your diagnosis. You may need chemotherapy or radiotherapy, which we are not equipped for.”"*
- This statement immediately introduces **overwhelming and potentially alarming information** (referral, chemotherapy, radiotherapy) without first establishing the diagnosis or assessing the patient's readiness to receive it.
- It prematurely jumps to treatment and logistics, potentially causing **unnecessary distress** before the patient has processed the core diagnosis.
*"Would you like to know all the details of your diagnosis, or would you prefer I just explain to you what our options are?""*
- While it attempts to assess the patient's preference for information, this question is a **closed-ended "either/or" choice** that might limit the patient's ability to express nuanced needs.
- It also prematurely introduces the idea of "options" without first explaining the diagnosis in an understandable context.
*"Your lab reports show that you have an acute myeloid leukemia"*
- This is a **direct and blunt delivery of a serious diagnosis** without any preparatory context or assessment of the patient's existing knowledge or emotional state.
- Delivering such news abruptly can be shocking and overwhelming, potentially **hindering effective communication** and rapport building.
Question 9: A 47-year-old woman comes to the physician for a mass in her left breast she noticed 2 days ago during breast self-examination. She has hypothyroidism treated with levothyroxine. There is no family history of breast cancer. Examination shows large, moderately ptotic breasts. The mass in her left breast is small (approximately 1 cm x 0.5 cm), firm, mobile, and painless. It is located 4 cm from her nipple-areolar complex at the 7 o'clock position. There are no changes in the skin or nipple, and there is no palpable axillary adenopathy. No masses are palpable in her right breast. A urine pregnancy test is negative. Mammogram showed a soft tissue mass with poorly defined margins. Core needle biopsy confirms a low-grade infiltrating ductal carcinoma. The pathological specimen is positive for estrogen receptors and negative for progesterone and human epidermal growth factor receptor 2 (HER2) receptors. Staging shows no distant metastatic disease. Which of the following is the most appropriate next step in management?
A. Lumpectomy with sentinel lymph node biopsy followed by hormone therapy
B. Nipple-sparing mastectomy with axillary lymph node dissection followed by hormone therapy
C. Nipple-sparing mastectomy with axillary lymph node dissection, followed by radiation and hormone therapy
D. Radical mastectomy followed by hormone therapy
E. Lumpectomy with sentinel lymph node biopsy, followed by radiation and hormone therapy (Correct Answer)
Explanation: **Lumpectomy with sentinel lymph node biopsy, followed by radiation and hormone therapy**
- The patient has **early-stage (T1N0M0) estrogen receptor (ER)-positive, HER2-negative invasive ductal carcinoma** suitable for **breast-conserving surgery (lumpectomy)**.
- **Lumpectomy** must be followed by **radiation therapy** to the remaining breast tissue to reduce the risk of local recurrence, and **endocrine therapy** (due to ER positivity) is indicated to reduce systemic recurrence risk.
- **Sentinel lymph node biopsy** is performed to stage the axilla; if positive, an axillary lymph node dissection may be indicated. However, in this case, the mass is small, and there is no palpable axillary adenopathy, making sentinel lymph node biopsy the appropriate initial step.
*Lumpectomy with sentinel lymph node biopsy followed by hormone therapy*
- While **lumpectomy with sentinel lymph node biopsy** and **hormone therapy** are part of the appropriate management, **radiation therapy** to the conserved breast is a critical component that is missing from this option.
- Omitting **radiation therapy** after lumpectomy for invasive breast cancer significantly increases the risk of local recurrence.
*Nipple-sparing mastectomy with axillary lymph node dissection followed by hormone therapy*
- A **nipple-sparing mastectomy** is a more aggressive surgical approach than typically required for a **small, early-stage tumor** like this, which is amenable to breast-conserving surgery.
- **Axillary lymph node dissection** is usually reserved for cases with clinically positive lymph nodes or a positive sentinel lymph node biopsy, not as an initial step when there is no palpable axillary adenopathy.
*Nipple-sparing mastectomy with axillary lymph node dissection, followed by radiation and hormone therapy*
- This option involves an **unnecessarily extensive surgical procedure (nipple-sparing mastectomy with axillary lymph node dissection)** for a **small (1cm x 0.5cm) early-stage tumor** that can be managed with breast-conserving therapy.
- While radiation and hormone therapy are relevant, the initial surgical choice is too aggressive given the clinical presentation.
*Radical mastectomy followed by hormone therapy*
- **Radical mastectomy** (which includes removal of the breast, underlying chest muscle, and axillary lymph nodes) is rarely performed today due to its significant morbidity and is not indicated for this **early-stage tumor**.
- **Modified radical mastectomy**, which removes the breast and axillary lymph nodes while preserving the chest muscle, is typically only considered if breast-conserving surgery is not feasible or desired, and **hormone therapy** would be indicated, but **radiation** may also be needed depending on other factors.
Question 10: A 56-year-old woman comes to the physician because she palpated a mass in her right breast during self-examination a week ago. Menarche was at the age of 14, and her last menstrual period was at the age of 51. Vital signs are within normal limits. Examination shows a nontender, firm and hard mass in the upper outer quadrant of the right breast. Mammography shows large, dense breasts, with a 1.7-cm mass in the right upper outer quadrant. The patient undergoes right upper outer quadrant lumpectomy with subsequent sentinel node biopsy, which reveals moderately differentiated invasive ductal carcinoma and micrometastasis to one axillary lymph node. There is no evidence of extranodal metastasis. The tumor tests positive for both estrogen and progesterone receptors and does not show human epidermal growth factor receptor 2 (HER2) over-expression. Flow-cytometry reveals aneuploid tumor cells. Which of the following factors has the greatest effect on this patient's prognosis?
A. Age
B. Tumor size
C. Hormone receptor status
D. Nodal status (Correct Answer)
E. HER2 receptor status
Explanation: **Nodal status**
- The presence of **micrometastasis to one axillary lymph node** is the *most significant prognostic indicator* in this patient's case.
- **Lymph node involvement** signifies systemic spread and is the strongest predictor of recurrence and overall survival in breast cancer.
*Age*
- While **age** can influence treatment choices and comorbidity, it is generally *less impactful on long-term prognosis* than nodal status.
- Very young or very old age can sometimes be associated with more aggressive disease or worse outcomes, but it is not the primary determinant.
*Tumor size*
- The **tumor size of 1.7 cm** is a prognostic factor, with larger tumors generally having a worse prognosis.
- However, for this patient, the **presence of lymph node metastasis** is a more powerful indicator of systemic disease than the primary tumor size alone.
*Hormone receptor status*
- **Positive estrogen and progesterone receptors** indicate that the tumor is likely to respond to endocrine therapies.
- This is a *favorable prognostic factor* as it opens up additional treatment options, but it does not outweigh the negative impact of nodal involvement.
*HER2 receptor status*
- **Absence of HER2 overexpression** is a positive factor, as HER2-positive cancers are generally more aggressive and require targeted therapy.
- However, while HER2 status guides treatment, the presence of **lymph node metastasis** still holds greater weight in determining overall prognosis.
Want unlimited practice?
Get full access to all questions, explanations, and performance tracking.
